Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report. HypertensionThrombosis and Stroke Share: Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me Forgot password? Click here
Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me